JRSIS Health Care Corporation
JRSS · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.05 | 8.42 | 0.00 | -0.21 |
| FCF Yield | -3.45% | 0.76% | 6.45% | 6.50% |
| EV / EBITDA | -27.97 | 2,388.36 | -84.39 | 15.97 |
| Quality | ||||
| ROIC | 214.21% | -23.97% | -1,331,706.33% | 4.88% |
| Gross Margin | 20.71% | 13.95% | -16,399.56% | 54.50% |
| Cash Conversion Ratio | 0.86 | -6.39 | -9.36 | 2.58 |
| Growth | ||||
| Revenue 3-Year CAGR | 145.84% | -57.28% | -86.43% | 12.16% |
| Free Cash Flow Growth | -185.07% | -82.95% | 10.59% | 15.24% |
| Safety | ||||
| Net Debt / EBITDA | 0.24 | 31.61 | 0.07 | 5.71 |
| Interest Coverage | -23.28 | -3.34 | -5.04 | 2.97 |
| Efficiency | ||||
| Inventory Turnover | 2.71 | 6.54 | -0.02 | 11.40 |
| Cash Conversion Cycle | -261.92 | 51.66 | -14,787.11 | 93.53 |